Medical injector

- AstraZeneca AB
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top front perspective view of a medical injector comprised of a medical injector and cartridge showing our new design;

FIG. 2 is a top view thereof,

FIG. 3 is a bottom view thereof;

FIG. 4 is a left side view thereof;

FIG. 5 is a right side view thereof;

FIG. 6 is a rear view thereof;

FIG. 7 is a front view thereof,

FIG. 8 is a top front perspective view of the medical injector of FIG. 1 comprised of a medicinal cartridge included within the medical injector in an open configuration as a set;

FIG. 9 is another top front perspective view of the medical injector of FIG. 1 comprised of a medicinal cartridge included within the medical injector on an open configuration as a set;

FIG. 10 is a top view of FIG. 8;

FIG. 11 is a top view of a medical injector of FIG. 1 and medicinal cartridge beside as a set; and,

FIG. 12 is a top front perspective view of the medical injector of FIG. 8 shown without the medicinal cartridge.

Claims

The ornamental design for a medical injector as shown and described.

Referenced Cited
U.S. Patent Documents
D670375 November 6, 2012 Corbin
D670376 November 6, 2012 Corbin
D696772 December 31, 2013 Schneider
D696775 December 31, 2013 Guarraia
D707352 June 17, 2014 Liu
D753291 April 5, 2016 Ratjen
D773649 December 6, 2016 Wohlfahrt
D782033 March 21, 2017 Ratjen
D789519 June 13, 2017 Ratjen
D819804 June 5, 2018 Knight
D878564 March 17, 2020 Clawson
D893021 August 11, 2020 Dyer
D1036844 July 30, 2024 Gradinarsky
20190269859 September 5, 2019 Jacobsen
20210196892 July 1, 2021 Dasbach
20230166046 June 1, 2023 Frost
20240424216 December 26, 2024 Halbig
20250161588 May 22, 2025 Scheurer
Foreign Patent Documents
202511339 February 2025 AU
202511340 February 2025 AU
7448238 January 2020 EP
8546816 June 2021 EP
6044227 September 2018 GB
Other references
  • Skytrofa Auto-Injector, Skytrofa, [Post date: Dec. 5, 2023], [Site seen: Sep. 3, 2025], URL: https://skytrofa.com/why-skytrofa/skytrofa-auto-injector/ (Year: 2023).
  • Bydureon® BCise™ for the Treatment of Type-2 Diabetes, AstraZeneca, [Post date: May 4, 2018], [Site seen: Sep. 3, 2025], URL: https://www.clinicaltrialsarena.com/projects/bydureon-bcise-treatment-type-2-diabetes/ (Year: 2018).
  • Prime Platform, Portal Instruments, [Post date: Nov. 14, 2024], [Site seen: Sep. 3, 2025], URL: https://www.portalinstruments.com/technology (Year: 2024).
Patent History
Patent number: D1150447
Type: Grant
Filed: Aug 26, 2024
Date of Patent: Sep 29, 2026
Assignee: AstraZeneca AB (Södertälje)
Inventors: Michael James Herd (Cambridge), Thomas James Etheridge (Cambridge), Kathryn Anna Thompson (Cambridge), John Edward Burke (Cambridge), Anthony Michael Strathern (Cambridge), Andrew David Chapman (Cambridge), Duncan Alexander Paterson (San Francisco, CA)
Primary Examiner: Jonathan J Han
Assistant Examiner: Gilbert B Ford
Application Number: 29/959,460